؉ cells from haemopoietic tissues. In LTBMC the production of GM-CFC from CD34 ؉ CCR1 ؊ cells was significantly higher (P Ͻ 0.02) than that from CD34 ؉ CCR1 ؉ cultures and the incidence of LTC-IC was 3-to 6-fold higher in the CD34 ؉ CCR1 ؊ cell fraction. In contrast, the cells responsible for high levels of engraftment in NOD/SCID mice were contained in the CD34 ؉ CCR1 ؉ cell fraction. The CD34 ؉ CCR1 ؉ cells engrafted to high levels in NOD/SCID and generated large numbers of progenitor cells. Therefore, we conclude that LTC-IC and SRC may be distinguished on the basis of expression of the chemokine receptor CCR1. Leukemia (2001) 15, 1092-1101.
Introduction
All mature blood cells arise from a small population of stem cells within the bone marrow microenvironment. These cells have the ability to regenerate the entire haemopoietic system following transplantation and are useful targets for gene therapy. The stem cells in the bone marrow are characterised by their capacity for extensive proliferation, differentiation and self renewal. Primitive haemopoietic cells that express these properties to different degrees have been detected in in vitro assays such as the long-term culture initiating cell (LTC-IC) assay 1, 2 and high proliferation potential colony-forming cell (HPP-CFC) assay. 3, 4 To evaluate the long-term in vivo repopulating capacity transplantation assays are required. These assays are generally performed in mice to define and characterise primitive murine haemopoietic cells with marrow repopulating ability (MRA). Similar assays have been developed that can detect human cells capable of repopulating the bone marrow of immunodeficient SCID or NOD/SCID mice. 5, 6 The cells that engraft in the murine bone marrow have been termed SCID repopulating cells (SRC) based on their ability to initiate multilineage human cell engraftment in the mouse. However, the relation-ship of SRC to other primitive cells such as LTC-IC is not clear. Previous studies showed that the LTC-IC from murine cultures could regenerate haemopoiesis in irradiated mice 7 suggesting significant overlap between LTC-IC and cells with marrow repopulating ability. Other investigators have also reported an overlap between human LTC-IC and cells that give rise to engraftment in immunodeficient mice or share features with the in vivo repopulating cells. 2, 8 In contrast, work involving cell purification and retrovirus gene marking have indicated that the SRC is biologically distinct and more primitive than LTC-IC. 5, 9, 10 A correlation between LTC-IC and reconstitution potential of the same cell population in vivo has not yet been reported. Thus, it would be advantageous to distinguish and examine these two cell populations in the appropriate assays.
Chemokines are an expanding family of small molecular weight proteins involved in the inflammatory response. There are two major groups within this family the ␣-or C-X-C chemokines and the ␤-or C-C chemokines. In haemopoiesis, much interest has focused on a ␤-chemokine, macrophage inflammatory protein-1 alpha (MIP-1␣), due to its ability to inhibit stem cell proliferation and protect against S phase-specific cell cycle cytotoxic agents. [11] [12] [13] [14] [15] [16] [17] Evidence for an effect of MIP-1␣ on LTC-IC was provided by Verfaillie who showed prolonged survival of LTC-IC in cultures containing MIP-1␣ IL-3 and stromal cell supernatant or heparan sulphate. [18] [19] [20] IL-3 and MIP-1␣ were also required for survival of primitive human haemopoietic cells with myeloid and lymphoid differentiation potential in vitro. 18, 21 Furthermore, both mRNA and protein for MIP-1␣ have been detected in the adherent stromal layers of long-term bone marrow cultures where the LTC-IC reside. 22, 23 As the action of MIP-1␣ on stem and progenitor cells is the result of direct interaction with the target cells, the responsive cells must bear the appropriate receptors for the chemokine. 24, 25 Using radioactively labelled or biotinylated MIP-1␣ ligand, [26] [27] [28] [29] receptors for MIP-1␣ were detected on CD34 + cells from normal and leukaemic haemopoietic tissue. Subsequently, four of the 10 C-C chemokine receptors identified were reported to bind MIP-1␣: CCR1, CCR3, CCR4 and CCR5. Later, CCR3 was shown to be specific for eotaxin 30 while TARC (thymocyte and activation regulated chemokine) was a highly specific biological ligand for CCR4. 31 As MIP-1␣ has several effects in haemopoiesis and can bind to more than one receptor, it is important to determine which receptor mediates specific effects. Although MIP-1␣ binds to CCR1 and CCR5 it is not known if either of these receptors are associated with the response of LTC-IC to MIP-1␣.
The aim of this study was to investigate if CD34 + cells expressing MIP-1␣ receptors sustained haemopoiesis in longterm culture and to examine the functional behaviour of CD34 + cells isolated on the basis of their CCR1 receptor expression in LTC-IC assays and in NOD/SCID mice. We have demonstrated previously by Northern blot that high levels of transcripts for CCR1 are present in CD34
+ haemopoietic 1093 cells. 28 This was also shown by Su et al 32 using RT-PCR. The same authors developed a polyclonal antibody with specificity for CCR1 and showed that the receptor was highly expressed on human bone marrow CD34
+ cells, monocytes, T cells and natural killer cells with very low levels present on granulocytes. 33 We report here that the CCR1 receptor is expressed at high levels on SRCs but that the receptor expression is reduced greatly on the LTC-ICs. However, some SRC are negative for CCR1.
Materials and mehtods

Samples
Bone marrow specimens were obtained with informed consent from allogeneic transplant donors. Cord blood collections were obtained from normal full-term deliveries and had local Ethical Committee approval.
Long-term culture on bone marrow stromal layers
Adherent bone marrow stromal layers were established as previously described. 34 Briefly, cultures were initiated with 2 × 10 6 /ml marrow cells in 10 ml Iscove's modified Dulbecco's medium (IMDM) at 350 mOsm/kg containing 10% (v/v) horse serum, 10% (v/v) foetal calf serum, 5 × 10 −7 m hydrocortisone in 25-cm 2 tissue culture flasks. The cultures were maintained at 33°C in 5% CO 2 in air. Each week half of the supernatant medium containing non-adherent cells was replaced with an equal volume of fresh medium. When the stromal layer was confluent, generally after 3-4 weeks, the cultures were irradiated with 15 Gy per culture and used as a stromal support.
To initiate long-term cultures, the medium was completely removed from the irradiated cultures and replaced with fresh medium. 5 × 10 3 cells from the relevant test cell populations were inoculated on the irradiated stromal layers and the cultures incubated at 33°C and 5% CO 2 in air. At the time of the weekly feed, the non-adherent cells in the culture supernatant were collected, counted and assayed for their content of clonogenic cells using the CFC-mix assay.
Long-term culture initiating cell assays (LTC-IC)
LTC-IC were assayed by limiting dilution using the murine stromal cell line M210-B4 as previously described. 35 Confluent cells were trypsinised with 0.05% (w/v) trypsin (Worthington Biochemical Corporation, Lakewood, NJ, USA) containing 5 mm EDTA, counted and resuspended at 10 5 cells/ml in RPMI 1640 medium containing 20% (v/v) FCS and 2 mm l-glutamine. Twenty thousand cells (200 l) were deposited per well in 30 replicates on a 96-well plate and cells incubated at 37°C for 24 to 48 h by which time the wells were 70-90% confluent. The cultures were irradiated at 80 Gy to halt further proliferation. After irradiation the medium was removed from the cultures and replaced with 200 l aliquots of test cells at the appropriate dilutions, chosen to be maximally informative at weeks 5-6 of the assay. 36 All plates were incubated at 33°C and fed weekly by removing half of the medium and replacing with fresh medium. At week 5, the contents of each well were plated in clonogenic assays to assess the presence of myeloid progenitors.
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Clonogenic assays
To assess the numbers of GM-CFC and BFU-E by colony formation, cells were plated in 1 ml containing 1.35% (w/v) methylcellulose (Sigma Aldrich, Poole, UK), 30% (v/v) FCS (Autogen Bioclear, Wilts, UK), 1% (w/v) (BSA), 10% (v/v) 5637 conditioned medium (from the EJ bladder carcinoma cell line) and 2 units erythropoietin (Epo). Triplicate cultures containing up to 10 5 cells/ml were plated and incubated for 14 days at 37°C in a humidified atmosphere of 5% CO 2 and 5% O 2 . Granulocyte/macrophage and erythroid colonies were scored according to standard criteria. 34 The presence of human colony-forming cells in the bone marrow of transplanted mice was determined by plating the bone marrow cells in methylcellulose cultures under conditions that are selective for the growth of human cells. These assays were performed by adding 2 × 10 5 cells from the bone marrow of transplanted mice to complete medium, StemGEM (Stem BioResearch Ltd, Villejuif, France) which contains human recombinant cytokines IL-3, IL-6, SCF, G-CSF, GM-CSF, IL-11 and Epo. After mixing the cells were plated in 35-mm Petri dishes (Falcon, Becton Dickinson, Oxford, UK) and cultures incubated in a humidified atmosphere for 14 days at 37°C. Control cultures of murine bone marrow did not show any colony formation.
CD34
+ cell selection CD34 + cells were isolated as previously described. 37 Briefly, bone marrow or cord blood mononuclear cells (MNC) were obtained by centrifugation over a Ficoll-Hypaque gradient (1.077 g/ml, Lymphoprep; Life Technologies, Paisley, UK). After centrifugation, the cells at the interface were removed, washed in phosphate-buffered saline (PBS) containing 0.5% (w/v) BSA and 5 mm EDTA (PBE) and incubated with CD34-conjugated immunomagnetic microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany). CD34 + cells were isolated by passing the microbead labelled cells through a column placed in a magnetic field that allowed retention of the target cells. The CD34 + cells were recovered by manually flushing the column with PBE buffer.
Receptor labelling with MIP-1␣ biotinylated ligand
Isolated CD34
+ cells were labelled with a Fluorokine Kit for Human MIP-1␣ (R & D Systems, Abingdon, UK) as previously described. 28, 29 Briefly, 10 l of biotinylated cytokine reagent was added to 25 l aliquots of washed cells (4 × 10 6 /ml) and incubated for 1 h at 4-8°C. At the end of the incubation period, 10 l of avidin-FITC reagent was added and the cells incubated for a further 30 min in the dark. After washing the cells twice with the buffer provided, the cells were analysed. The specificity of MIP-1␣ binding had previously been checked using two controls:
38 biotinylated MIP-1␣ could be competed off the cells by use of an excess of unlabelled MIP-1␣ or a specific blocking antibody to MIP-1␣ could be used to reduce the number of cells stained to less than 1%. As a negative control, we used a second sample of cells incubated with a biotinylated control reagent (supplied by the manufacturers) and CD34-PE. This also resulted in Ͻ1% staining of the control cells. Data acquisition performed using PCLYSYS and at least 20 000 events were analysed for each sample. Defined cell populations were sorted on a FACS Vantage flow cytometer (Becton Dickinson, Oxford, UK).
Antibody labelling for MIP-1␣ receptors
The rabbit polyclonal antibody for the CCR1 receptor was prepared as described previously.
33 CD34 + cells were incubated with 25 g/ml of CCR1 antibody for 20 to 30 min at 4°C. After washing in PBS/1% BSA, the cells were then labelled with a swine anti-rabbit FITC-conjugated antibody (DAKO Ltd, Ely, UK) diluted 1:15 for a further 20 min in the cold. 10 l of CD34-PE-conjugated antibody (HPCA-2, Becton Dickinson) was added to the cells during the last 10 min of incubation. After washing in ice-cold PBE, the cells were analysed and sorted by flow cytometry. Control cells were labelled with a secondary FITC-conjugated and an isotype-matched PEconjugated antibody or with the secondary FITC-conjugated antibody and CD34-PE to allow more stringent gate settings for FACS sorting. Both controls gave similar results.
Transplantation and analysis of human cells in NOD/SCID mice
Human cells were transplanted into 6-to 8-week-old NOD/LtSz-scid/scid (NOD/SCID) mice obtained from the Jackson Laboratory (Bar Harbor, ME, USA). Animals were maintained in microisolators in a pathogen-free environment. The mice were given a total body irradiation of 3.5 Gy (0.83 Gy/h) from a Cobalt ␥-irradiator prior to intravenous injection of target cells. Eight to nine weeks after transplantation mice were sacrificed and the bone marrow analysed for the presence of human cells as previously described. 37 Aliquots of 1-5 × 10 5 bone marrow cells were labelled with CD45-FITC conjugated antibody (Pharmingen, San Diego, CA, USA) for 25 min at 4°C. Additional aliquots were doublestained with CD45-FITC and CD34-PE (HPCA-2) or isotypeconjugated antibodies. After labelling, red blood cells were lysed, washed in PBS/BSA and resuspended in the same buffer containing 2 mg/ml propidium iodide (PI) prior to analysis by flow cytometry.
Statistical analysis
Analysis for significance was performed using the Wilcoxon rank sum test, Mann-Whitney U test and Student's t-test. Levels of significance (P values) are reported at the 5% level. The frequency of LTC-IC in the cell populations was calculated by Poisson statistics as reported elsewhere. 
Results
Cord blood CD34 + cells labelled with biotinylated MIP-1␣ sustain haemopoiesis in long-term cultures
We have previously used biotinylated MIP-1␣ ligand to analyse MIP-1␣ receptor expression on CD34 + cells. 28, 29 This approach identifies all the cells bearing MIP-1␣ receptors and does not interfere with the biological response of the cells. Figure 1 illustrates the gating strategy to identify and obtain the two cell populations. The cells were collected and 5000 cells from each population inoculated on irradiated bone marrow stroma. The total number of non-adherent cells and progenitor cells for each culture was assessed at regular intervals. Figure 2a summarises four experiments and shows that the GM-CFC progenitor cell numbers generated by the MR + cells was greater than those produced in the MR − cultures. Numbers of GM-CFC reached a maximum around week 3 and were maintained at a consistently higher level up to week 8 of culture. The numbers of GM-CFC generated by the MR − were on average 5-fold lower over the first 5 weeks of culture and in one of four experiments, no GM-CFC were detected after week 5. However, a consistent difference, at least 10-fold, was noted around week 6 between the MR + and MR − cultures. The difference in generation of GM-CFC between MR + and MR − cultures was highly significant (P Ͻ 0.006) over the entire culture period. These data indicated that the MR + cell fraction was enriched in LTCICs as determined by the consistent production of greater numbers of progenitors.
The number of non-adherent cells per culture generated by the MR + cells increased 7-fold between week 1 and week 4 as shown in Figure 2b . This steady output of cells was maintained for a further 2 weeks after which cell numbers produced slowly decreased. In contrast, the non-adherent cells from the MR − cell cultures increased by about 3-fold by week 4 followed by a decline after week 5. Statistical analysis showed that the difference in the numbers of non-adherent cells generated from MR + and MR − cultures was highly significant (P Ͻ 0.006). These data indicate that the higher numbers of GM-CFC resulted in a higher level of production of mature cells.
CCR1 receptor expression on CD34 + cells from cord blood and bone marrow
Although the use of the biotinylated ligand established that the LTC-IC expressed receptors for MIP-1␣, this approach does not answer the question as to which receptor of the several receptors that bind MIP-1␣, is responsible for the effect. We examined whether CCR1 was the receptor expressed on LTC-IC using an anti-CCR1 antibody. First, the expression of CCR1 on cord blood and bone marrow CD34 + cells was assessed by flow cytometry. Clear and distinct staining was observed with the anti-CCR1 antibody. The results in Table 1 show that the majority of CD34 + cells from cord blood and bone marrow expressed CCR1. Although the proportion of positive cells was higher on cord blood than in bone marrow, the difference was not statistically significant (P Ͻ 0.09). 
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CCR1
+ and CD34 + CCR1 − cell fractions were separated using the sorting gates defined in Figure 3 . Individual populations were seeded on irradiated bone marrow stroma to examine their ability to sustain haemopoiesis in long-term culture. There was a difference in the GM-CFC content in the input populations as the majority of GM-CFC progenitors segregate to the CD34 +
+ population with fewer GM-CFC detectable among the CD34 +
− cells. 39 Nevertheless, as shown in Figure 4a , GM-CFC numbers from the cord blood CD34 +
+ population declined steadily over the entire culture period indicating a slow decline in the numbers present in the original inoculum. In contrast, within 2-3 weeks, the number of GM-CFC progenitors generated from the CD34 +
− cells increased and then exceeded those of the CD34 +
+ population. Beyond week 3, the average production of GM-CFC from the CD34 +
− cultures was significantly different (P Ͻ 0.01) and remained consistently higher compared to cultures initiated with the CD34
The level of mature cell production as measured by the numbers of non-adherent cells in the supernatant is shown in Figure 4b . The cell numbers in both cultures increased up to weeks 4-5. Beyond week 4, the CD34 +
− cultures maintained higher cell numbers than those of the CD34 + CCR1 + cultures although the difference between the non-adherent cell numbers from the two cultures was not as marked as that observed for GM-CFC production.
In two experiments the adherent layers were examined at week 5 for their progenitor cell content. It was clear that the cultures initiated with CD34 + CCR1 − cells contained substantially more progenitors compared to those from the CD34 +
+ groups as shown in Figure 5 . A calculation of the total numbers in the adherent layer shows that they were at least five times higher in the cultures initiated by CCR1 production was not reflected in the numbers of non-adherent cells generated from the two cell populations.
Frequency of LTC-IC in the CD34
To investigate the frequency of LTC-ICs in the CCR1 + and CCR1 − population of CD34 + cells isolated from cord blood, the test cell populations were prepared at six dilutions ranging from 25 cells/ml to 1000 cells/ml estimated to be the most informative. 40 The contents of individual wells were assayed in clonogenic assays after 5 weeks co-culture on the stromal layers. Data from one of two experiments are shown in Figure 6 . The frequency of negative wells was determined and the frequency of LTC-IC in the original test cell suspensions was calculated. In two separate experiments frequencies ranged between 1:7-1:18 LTC-IC in the CD34 
CCR1
− fraction. This compares well with our data on the incidence of LTC-IC using other markers for characterisation of primitive cell populations as detailed on Table 2 . The incidence of LTC-IC in the CD34 +
− subset is very similar to that obtained for CD34 +
CD38
− cells. 
Engraftment of CD34
CCR1
− cells is shown in Figure 8 where the cells showing the highest levels of engraftment were enriched in the CD34 +
+ fraction although there was some variation among individual animals. There was significantly higher activity in the CD34 
− population was reduced in SRC 
Figure 5
Progenitor cell content, GM-CFC, in the adherent layer of cultures initiated with CCR1 + or CCR1 − cells at week 5. Adherent layers were removed and 1-2 × 10 5 cells plated in clonogenic assays. Progenitor cell content calculated from total number of cells present in the adherent layers.
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Figure 6
Limiting dilution analysis for LTC-IC from CCR1 + and CCR1 − cultures. Decreasing numbers of CCR1 + and CCR1 − cells were seeded on a supportive stroma. Thirty replicates of 200 l aliquots at six dilutions ranging from 25 to 1000 cells/ml were deposited on the cell layer in each well of a 96-well plate. The number of wells containing clonogenic cells after 5 weeks was determined by plating the entire contents of each well in clonogenic assays. The incidence of LTC-IC in the starting population is the reciprocal of the concentration of test cells that give 37% negative cultures. One of two experiments is illustrated. Full results are shown in Table 2 . Mean ± s.e.m.
Figure 7
Relationship between number of cells transplanted and level of engraftment. Purified cells CD34 +
CCR1
+ were injected at the doses indicated and the level of human cells present in the murine bone marrow determined 8 weeks later by labelling with the CD45 human-specific leukocyte marker. Each data point represents the results from three to four animals expressed as mean ± s.e.m.
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Figure 8
Summary of engraftment of CCR1 + and CCR1 − cord blood cells in NOD/SCID mice. A total of 21 animals in three separate experiments were injected with between 5000 and 50 000 selected CCR1 + or CCR1 − cells. The percentage of human cell engraftment was determined by flow cytometry using the human pan-leucocyte marker CD45, 8 weeks after transplantation. Each circle represents one animal and there was a significant difference (P Ͻ 0.01) in the percentage engraftment between the CCR1 + and CCR1 − cells as assessed by the Mann-Whitney U test for significance.
activity and was further confirmed by statistical analysis which showed a significant difference between the two populations (P Ͻ 0.01). To quantitate human myeloid engraftment the bone marrow cells of sacrificed mice were cultured in colonyforming assays that allow human but not mouse colony growth. 41, 42 It was clear that: (1) the number of human cells detected per femur increased in accordance with the higher levels of engraftment shown by the numbers of CD45 + cells; and (2) the CCR1 + cells were more effective in repopulating NOD/SCID mice. There was a mean of 4000-fold expansion of human cells per femur of recipient mice receiving CCR1 − cells vs a 27 800-fold expansion for those transplanted with CCR1 + cells (Table 3) . This difference was also reflected in mean numbers of 597 vs 2900 CFC per femur, respectively. 
Discussion
The SRC and LTC-IC assays are widely used to characterise human primitive haemopoietic cells although it is not clear whether these are distinct cell types. CD34
+ cell populations were used as they contain both LTC-IC and SRC. 5, 10, 37, [43] [44] [45] [46] [47] The experiments reported here show that the CD34
+ cord blood cells expressing CCR1 were significantly enriched (P Ͻ 0.01) in SRC but not in LTC-IC. In contrast, CD34
+ cells lacking the CCR1 antigen had reduced engraftment potential in NOD/SCID mice but were able to maintain haemopoiesis for several weeks in culture.
The presence of both lymphoid cells and a variety of myeloid progenitors in the engrafted mice has been taken as evidence that the NOD/SCID assay detects a more primitive cell in the human haemopoietic system than the LTC-IC. 5, 10 However, single primitive CD34
− human cells can differentiate in vitro into cells with myeloid, NK, B and T lymphoid phenotypes illustrating their multilineage potential. 48, 49 Bhatia and colleagues showed that SRC are found exclusively in the CD34 + CD38 − fraction 10 and we have previously shown that in cord blood, LTC-IC activity is also restricted to the CD34 +
CD38
− fraction. 46 Consequently, separation of CD34
− cells alone is not sufficient to distinguish LTC-IC from SRC.
Previous reports had indicated that MIP-1␣ was an important component for maintenance of LTC-IC 18,20 so it was expected that LTC-IC must express MIP-1␣ receptors. Our current studies confirm that in long-term culture, sustained haemopoiesis was associated with the cells expressing higher levels of MIP-1␣ receptors (Figure 2 ). This population should be enriched in LTC-IC. This concept was supported by the highly significant difference in the generation of GM-CFC progenitors between the MR + and MR − cell populations ( Figure 2 ). However, the use of the biotinylated MIP-1␣ is not sufficient to discriminate between the different MIP-1␣ receptors. Therefore, receptor specific antibodies are required. When CD34 + cells were separated into CCR1 + and CCR1 − subpopulations using an anti-CCR1 antibody, despite the fact that CCR1 was expressed on a high proportion of CD34 + cells, the CCR1 − fraction was enriched for LTC-IC activity. This indicated that although LTC-IC have MIP-1␣ receptors, CCR1 is not the subtype present on these cells. In addition, more progenitors were detected in the adherent layer of cultures initiated with the CCR1 − cells compared to the CCR1 + cells at week 5 of culture emphasising the increased haemopoietic activity of these LTC.
Analysis of the incidence of LTC-IC in the CCR1
− population provided further evidence that the majority of LTC-IC were present in this cell subset. Although it is difficult to compare LTC-IC frequencies with published data unless similar stromal feeders and culture conditions are used, 50 our data are in broad agreement with the LTC-IC frequencies determined by other investigators in cord blood CD34 + primitive subsets.
50,51
The difference in GM-CFC numbers generated by the CCR1 − and CCR1 + cultures was not reflected in the number of non-adherent cells generated. This has been observed previously in LTC of patients with marrow damage where the difference in GM-CFC did not mirror the number of total cells. 52 At present, the only other MIP-1␣ receptor characterised is CCR5. This is the major co-receptor for M-tropic HIV-1 entry into cells. [53] [54] [55] [56] [57] Messenger RNA for CCR5 was inconsistently detected, if at all, in highly purified CD34 + cells from bone marrow. 58 Attempts to obtain sufficient numbers for long-term culture experiments were hampered by the low proportion of
CD34
+ cells expressing CCR5 (Ͻ1%, data not shown) so whether the CCR5 receptor is the responsive receptor on LTC-IC is still not known. At present, CCR5 seems an unlikely candidate as natural polymorphisms of CCR5 exist and are not associated with any detrimental phenotype. Individuals with a 32-base pair deletion in the CCR5 gene, which abolishes cell surface expression of the receptor, are haematologically normal. [59] [60] [61] To date, there are no reports on the effect of a complete absence of CCR5 in humans or the consequence of targeted disruption of the CCR5 gene. Overall, the evidence suggests the existence of another MIP-1␣ receptor present on LTC-IC.
Specific homing receptors on the cell surface are required to ensure localisation of cells to distinct sites such as bone marrow. Although an ␣-chemokine receptor CXCR4 was critical for engraftment of transplanted human cells in NOD/SCID mice, 62 little is known about the function of the ␤-chemokine receptors in this regard. CCR1 was shown to be the receptor involved in the migratory response of human monocytes to MIP-1␣ 63 and upregulation of CCR1 promoted the migration of T cells. 64 In mice without functional CCR1 receptors (produced by targeted gene disruption), MIP-1␣ could not induce in vivo mobilisation of haemopoietic progenitor cells to the blood. 65 If CCR1 is associated with migration and/or homing this may explain our results where enhanced engraftment was observed in the bone marrow of NOD/SCID mice transplanted with CCR1 + cells. The work outlined here should facilitate the purification of more defined populations and assist in establishing techniques to improve gene transfer efficiency in either SRC or LTC-IC. With the increasing interest in ex vivo expansion protocols and gene transfer protocols, it would be prudent to measure both LTC-IC and the SRC as assessing one parameter alone or just the generation of CD34 + cells may be misleading. In conclusion, our data confirm that LTC-IC express MIP-1␣ receptors but rule out CCR1 as the receptor subtype present on LTC-IC. As the data also demonstrate preferential expression of CCR1 on SRC, we report for the first time that SRC and LTC-IC can be distinguished based on the expression of the chemokine receptor CCR1. The use of this antibody should allow more detailed functional studies and clarify the relationship between these two cell populations.
+
/CD33
− cells reselected from macrophage inflammatroy protein 1␣ + interleukin 3-supplemented 'stroma-noncontact' cultures are highly enriched for long-term bone marrow culture initiating cells. 
